search
Back to results

Image Discovering Early Lung Cancer Project (IDEALCAP)

Primary Purpose

Lung Cancer

Status
Unknown status
Phase
Phase 2
Locations
Taiwan
Study Type
Interventional
Intervention
Low-dose computed tomography (LDCT)
Sponsored by
Cathay General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lung Cancer focused on measuring Lung cancer, Low-dose computed tomography scan

Eligibility Criteria

50 Years - 74 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 50-74 years
  • 30 or more pack-years of cigarette smoking history
  • Former smokers: quit smoking within the previous 15 years
  • Ability to tolerate CT procedure
  • Signed informed consent

Exclusion Criteria:

  • Severe uncontrolled heart, vascular, respiratory or endocrine pathology.
  • Life-expectancy less than 1 year
  • History of lung cancer
  • Acute respiratory disease
  • Hemoptysis.
  • Weight loss more than 6.8 kg in the 12 months prior to eligibility assessment
  • Participation in other cancer clinical trial
  • Chest CT examination in the 12 months prior to eligibility assessment.

Sites / Locations

  • Lotung Pohai General hospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Low-dose computed tomography (LDCT)

Arm Description

Patients will have one baseline LDCT scan.

Outcomes

Primary Outcome Measures

Lung cancer detection rate
Assess number of lung cancer diagnoses after radiological and morphological verification of positive lung nodules.

Secondary Outcome Measures

Lung cancer mortality
Assess lung cancer mortality in the screened group within next 5 years.
All-cause mortality
Assess all-cause mortality mortality within next 5 years.
Nodule detection rate
Estimate nodule detection rate, types (solid, part-solid, or ground glass opacity) and sizes of lung nodules found.
Smoking cessation rate
Assess smoking cessation rate in the screened group within next one year.

Full Information

First Posted
July 28, 2013
Last Updated
July 31, 2013
Sponsor
Cathay General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01914458
Brief Title
Image Discovering Early Lung Cancer Project
Acronym
IDEALCAP
Official Title
Low-Dose Computed Tomography for Lung Cancer Screening in High Risk Asymptomatic Patients: the Taiwan Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2013
Overall Recruitment Status
Unknown status
Study Start Date
February 2013 (undefined)
Primary Completion Date
January 2018 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cathay General Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Lung cancer is the leading cause of cancer related death in Taiwan and world wide. The application of low dose helical computed tomography (CT) has been the milestone of lung cancer screening. Recently, The National Lung Screening Trial (NLST) shows screening with low-dose CT could reduce mortality from lung cancer. We conducted this clinical trial to determine the efficacy of low dose CT in early lung cancer screening in Taiwan.
Detailed Description
This is a single center, single arm, non-randomized prospective study. We plan to enroll persons between 50 and 74 years in age, who had cigarette smoking of at least 30 pack-years, and, if former smokers, had quit within the previous 15 years. Persons who had previously received a diagnosis of lung cancer, had undergone chest CT within 18 months before enrollment, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg in the preceding year were excluded. All the participants should complete a questionnaire that covers many topics, including demographic characteristics and smoking behavior. We also plan to collect additional data for planned analyses of cost-effectiveness, and smoking cessation. Lung-cancer got by biopsy and other biospecimens are available to researchers through a peer-review process All screening examinations are planed to perform in accordance with a standard protocol, developed by medical physicists associated with the trial, that specified acceptable characteristics of the machine and acquisition variables. All low-dose CT scans are acquired with the use of multidetector scanners with a minimum of 16 channels. IDEALCAP radiologists are certified by appropriate agencies or boards and has completed training in image acquisition; radiologists also has completed training in image quality and standardized image interpretation. Images are interpreted first in isolation and then in comparison with available historical images and images from prior IDEALCAP screening examinations. IDEALCAP primary analysis is the detection rate of lung cancer. Secondary analysis include the detection rate of lung nodule, 5-year survival rate of persons with lung cancer who receive standard surgical treatment, 5-year survival rate of persons with lung cancer who receive alternative treatment other than standard surgical treatment (ex. Radiotherapy, chemotherapy or target therapy), the correlation of CT images and cigarette smoking history, the correlation of CT images and pulmonary function. Key Word: low dose computed-tomography (LDCT), lung cancer screening

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer
Keywords
Lung cancer, Low-dose computed tomography scan

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low-dose computed tomography (LDCT)
Arm Type
Experimental
Arm Description
Patients will have one baseline LDCT scan.
Intervention Type
Procedure
Intervention Name(s)
Low-dose computed tomography (LDCT)
Other Intervention Name(s)
LDCT scan
Intervention Description
Low-dose computed tomography scan
Primary Outcome Measure Information:
Title
Lung cancer detection rate
Description
Assess number of lung cancer diagnoses after radiological and morphological verification of positive lung nodules.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Lung cancer mortality
Description
Assess lung cancer mortality in the screened group within next 5 years.
Time Frame
5 years
Title
All-cause mortality
Description
Assess all-cause mortality mortality within next 5 years.
Time Frame
5 years
Title
Nodule detection rate
Description
Estimate nodule detection rate, types (solid, part-solid, or ground glass opacity) and sizes of lung nodules found.
Time Frame
3 months
Title
Smoking cessation rate
Description
Assess smoking cessation rate in the screened group within next one year.
Time Frame
one year
Other Pre-specified Outcome Measures:
Title
Coronary artery calcification
Description
Estimate coronary artery calcification score (Agatston Score)in the screened group.
Time Frame
3 months
Title
Incidence rate of cardiovascular accident
Description
Incidence rate of cardiovascular accident stratified by coronary artery calcification score in the screened group within next 5 years.
Time Frame
5 years
Title
Diagnosis accuracy of COPD diagnosis by low-dose computed tomography(CT)
Description
Assess diagnosis accuracy of COPD diagnosis by low-dose computed tomography(CT) (CT emphysema, CT air trapping) according to the reference standard of pulmonary function tests.
Time Frame
2 years
Title
Lung nodules management
Description
Assess algorithms for lung nodules management in a regional general hospital in Taiwan.
Time Frame
12 months
Title
Frequency of diagnostic procedures
Description
Estimate the frequency of diagnostic procedures, types of invasive and non-invasive procedures performed in a regional hospital in Taiwan.
Time Frame
12 months
Title
Complication of diagnostic procedures
Description
Assess the complication rate after diagnostic procedures performed after screening in a regional hospital in Taiwan. Procedures include baseline LDCT.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 50-74 years 30 or more pack-years of cigarette smoking history Former smokers: quit smoking within the previous 15 years Ability to tolerate CT procedure Signed informed consent Exclusion Criteria: Severe uncontrolled heart, vascular, respiratory or endocrine pathology. Life-expectancy less than 1 year History of lung cancer Acute respiratory disease Hemoptysis. Weight loss more than 6.8 kg in the 12 months prior to eligibility assessment Participation in other cancer clinical trial Chest CT examination in the 12 months prior to eligibility assessment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chung-Huang Chan, Doctor
Phone
886-3-9543131
Ext
3030
Email
chchantaipei@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Wei-Chun Lin, Doctor
Phone
886-3-9543131
Ext
2430
Email
bizzarefish@yahoo.com.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chung-Huang Hubert Chan, Doctor
Organizational Affiliation
CH Chan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lotung Pohai General hospital
City
Lotung
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chung-Huang Hubert Chan, Doctor

12. IPD Sharing Statement

Learn more about this trial

Image Discovering Early Lung Cancer Project

We'll reach out to this number within 24 hrs